Search

Your search keyword '"William Greenhalf"' showing total 78 results

Search Constraints

Start Over You searched for: Author "William Greenhalf" Remove constraint Author: "William Greenhalf" Language english Remove constraint Language: english
78 results on '"William Greenhalf"'

Search Results

1. Long Covid: a global health issue – a prospective, cohort study set in four continents

2. 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

3. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

4. Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways

5. Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation

6. Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning

7. Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

8. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer

9. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

10. The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements

11. The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer

12. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

13. Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

14. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

15. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes

16. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk

17. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

18. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

19. Natural history of SPINK1 germline mutation related-pancreatitis

20. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

21. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.

22. Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.

23. Somatic mutations in exocrine pancreatic tumors: association with patient survival.

24. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue.

25. Pancreatic cancer susceptibility loci and their role in survival.

27. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

28. Genetic and non-genetic risk factors for early-onset pancreatic cancer

29. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer

30. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

31. Wild-type N-Ras Complements Mutant K-Ras in Pancreatic Cancer Cell Lines but K-Ras has a Specific Role in Cell Cycle Independent Regulation of G2 Cyclins

32. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

33. Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection

34. Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

35. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

36. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

37. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

38. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

39. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

40. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

41. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19 a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

42. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

43. The value of open-source clinical science in pandemic response

44. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes

45. Development and validation of the ISARIC 4C deterioration model for adults hospitalised with COVID-19: a prospective cohort study

46. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

47. The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements

48. Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk

49. Association of variants of genes involved in mitochondrial metabolism with pancreatic cancer risk

50. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium

Catalog

Books, media, physical & digital resources